PMVP ▼ -2.5% - PMV Pharmaceuticals, Inc. $PMVP - PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities PMV Pharmaceuticals announced pricing of an oversubscribed $50 million public offering of securities, which typically results in immediate dilution to existing shareholders through the issuance of new shares. The stock declined 2.5% on the news, a common market response to equity offerings despite the strong demand that oversubscription indicates. 31-AUG-2026 11:03 PM ET